Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis

People with cystic fibrosis (pwCF) were considered to be clinically vulnerable to COVID-19 and were therefore given priority in the vaccination campaign. Vaccines induced a humoral response in these patients that was comparable to the response observed among the general population. However, the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Alicandro, G., Orena, B.S., Rosazza, C., Cariani, L., Russo, M., Zatelli, M., Badolato, R., Gramegna, A., Blasi, F., Daccò, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201328/
https://www.ncbi.nlm.nih.gov/pubmed/37263872
http://dx.doi.org/10.1016/j.vaccine.2023.05.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201328/
https://www.ncbi.nlm.nih.gov/pubmed/37263872
http://dx.doi.org/10.1016/j.vaccine.2023.05.041

Ejemplares similares